{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"familial-dysfibrinogenemia","columns":[{"gene":"","key":"population-61d0f0897492adfa2591","label":"Congenital dysfibrinogenemia","mondoId":"MONDO:0014452","onsetQualifier":null,"originColumnKey":"MONDO:0014452/OMIM:616004","originalViews":[{"key":"MONDO:0014452/OMIM:616004","label":"Congenital dysfibrinogenemia","scopeLabel":"OMIM:616004","sourceScope":"Native source population. Automatically eligible unique exact-native equivalence; not clinically reviewed."}],"recordKeys":["a12e110c32a7d677046df3b2bb17a1e2721b6f7fea55a330012054027026bfd7"],"recordQualifiers":{},"scopeLabel":"OMIM:616004","sourceIds":["OMIM:616004"],"sourceScope":"Native source population. Automatically eligible unique exact-native equivalence; not clinically reviewed."},{"gene":"","key":"population-84475c6afede4fa2fc0f","label":"Familial dysfibrinogenemia","mondoId":"MONDO:0014452","onsetQualifier":null,"originColumnKey":"MONDO:0014452/ORPHA:98881","originalViews":[{"key":"MONDO:0014452/ORPHA:98881","label":"Familial dysfibrinogenemia","scopeLabel":"ORPHA:98881","sourceScope":"Native source population. Automatically eligible unique exact-native equivalence; not clinically reviewed."}],"recordKeys":["1ac71f86104293d5b260ffd8076e471517bb78bccc6f5498e7450386bddfd828","46cec9f76469b192d40797bcd9e526db73cbb82c638f14838eda478caa4c3589","7ae95de56efd46717dec4c6ab5e352bae0988dcaff07f165de79f5c619744abd","84e864d26913922bf46958e7d501fe72d0e085a0ea1e2ed9ef9d8e84b4b67d1c","a9036dbfc729acb9db8bca2c81d1dd068ffecb3c18008880ddf633444a8530cc"],"recordQualifiers":{},"scopeLabel":"ORPHA:98881","sourceIds":["ORPHA:98881"],"sourceScope":"Native source population. Automatically eligible unique exact-native equivalence; not clinically reviewed."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-61d0f0897492adfa2591","population-84475c6afede4fa2fc0f"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001892","HP:0000421","HP:0002239","HP:0000225","HP:0001934","HP:0004936"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":1,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":6,"sourceGroups":{"orphanet":5,"published":1}},"features":[{"hpoId":"HP:0001892","label":"Abnormal bleeding","primary":true},{"hpoId":"HP:0000421","label":"Epistaxis","primary":true},{"hpoId":"HP:0002239","label":"Gastrointestinal hemorrhage","primary":true},{"hpoId":"HP:0000225","label":"Gingival bleeding","primary":true},{"hpoId":"HP:0001934","label":"Persistent bleeding after trauma","primary":true},{"hpoId":"HP:0004936","label":"Venous thrombosis","primary":true}],"ledeHtml":"Dysfibrinogenemia is a coagulation (clotting) disorder characterized by having an abnormal form of fibrinogen. Fibrinogen is a protein produced by the liver which helps control bleeding by helping blood clots to form. Having abnormal fibrinogen results in defective clot formation and can cause an increased or decreased ability to clot. Dysfibrinogenemias may be inherited (congenital) or acquired. Congenital Dysfibrinogenemia is rare. About 40% of people with this form have no symptoms. About 50% have a bleeding disorder, and the remaining 10% have either a thrombotic disorder (excessive clotting) or both bleeding and thrombotic disorders. Congenital Dysfibrinogenemias may be caused by genetic changes in the FGA, FGB or FGG genes. Inheritance is most often autosomal dominant or codominant, but can also be autosomal recessive. Whether a person has no symptoms, a bleeding tendency, or an increased risk of thrombosis depends on the effect of their specific genetic change(s). Acquired Dysfibrinogenemia is more common than the congenital form and is associated with liver disease such as cirrhosis, liver tumors, or hepatitis.","mondoId":"MONDO:0014452","node":{"canonicalSlug":"familial-dysfibrinogenemia","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Familial dysfibrinogenemia","originalSourceId":"ORPHA:98881","paragraphs":["Dysfibrinogenemia is a coagulation (clotting) disorder characterized by having an abnormal form of fibrinogen. Fibrinogen is a protein produced by the liver which helps control bleeding by helping blood clots to form. Having abnormal fibrinogen results in defective clot formation and can cause an increased or decreased ability to clot. Dysfibrinogenemias may be inherited (congenital) or acquired. Congenital Dysfibrinogenemia is rare. About 40% of people with this form have no symptoms. About 50% have a bleeding disorder, and the remaining 10% have either a thrombotic disorder (excessive clotting) or both bleeding and thrombotic disorders. Congenital Dysfibrinogenemias may be caused by genetic changes in the FGA, FGB or FGG genes. Inheritance is most often autosomal dominant or codominant, but can also be autosomal recessive. Whether a person has no symptoms, a bleeding tendency, or an increased risk of thrombosis depends on the effect of their specific genetic change(s). Acquired Dysfibrinogenemia is more common than the congenital form and is associated with liver disease such as cirrhosis, liver tumors, or hepatitis."],"rawAttribution":"MONDO:0014452","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:38:37Z","upstream":"GARD:0002004","url":"https://rarediseases.info.nih.gov/diseases/2004"},"ownColumnKeys":["population-61d0f0897492adfa2591","population-84475c6afede4fa2fc0f"],"publication":"published","relationships":[{"kind":"parent","label":"congenital fibrinogen deficiency","mondoId":"MONDO:0018060","slug":"congenital-fibrinogen-deficiency"},{"kind":"child","label":"congenital afibrinogenemia","mondoId":"MONDO:0008737","slug":"congenital-afibrinogenemia"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"1ac71f86104293d5b260ffd8076e471517bb78bccc6f5498e7450386bddfd828","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:98881","disease_name":"Familial dysfibrinogenemia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000225","is_excluded":false,"label":"Gingival bleeding","onset_id":null,"reference":"ORPHA:98881","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"46cec9f76469b192d40797bcd9e526db73cbb82c638f14838eda478caa4c3589","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:98881","disease_name":"Familial dysfibrinogenemia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002239","is_excluded":false,"label":"Gastrointestinal hemorrhage","onset_id":null,"reference":"ORPHA:98881","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7ae95de56efd46717dec4c6ab5e352bae0988dcaff07f165de79f5c619744abd","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:98881","disease_name":"Familial dysfibrinogenemia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000421","is_excluded":false,"label":"Epistaxis","onset_id":null,"reference":"ORPHA:98881","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"84e864d26913922bf46958e7d501fe72d0e085a0ea1e2ed9ef9d8e84b4b67d1c","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:98881","disease_name":"Familial dysfibrinogenemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004936","is_excluded":false,"label":"Venous thrombosis","onset_id":null,"reference":"ORPHA:98881","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"a12e110c32a7d677046df3b2bb17a1e2721b6f7fea55a330012054027026bfd7","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616004","disease_name":"Congenital dysfibrinogenemia","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001934","is_excluded":false,"label":"Persistent bleeding after trauma","onset_id":null,"reference":"PMID:14615374","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"a9036dbfc729acb9db8bca2c81d1dd068ffecb3c18008880ddf633444a8530cc","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:98881","disease_name":"Familial dysfibrinogenemia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001892","is_excluded":false,"label":"Abnormal bleeding","onset_id":null,"reference":"ORPHA:98881","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/2004\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0014452\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0002004</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Dysfibrinogenemia is a coagulation (clotting) disorder characterized by having an abnormal form of fibrinogen. Fibrinogen is a protein produced by the liver which helps control bleeding by helping blood clots to form. Having abnormal fibrinogen results in defective clot formation and can cause an increased or decreased ability to clot. Dysfibrinogenemias may be inherited (congenital) or acquired. Congenital Dysfibrinogenemia is rare. About 40% of people with this form have no symptoms. About 50% have a bleeding disorder, and the remaining 10% have either a thrombotic disorder (excessive clotting) or both bleeding and thrombotic disorders. Congenital Dysfibrinogenemias may be caused by genetic changes in the FGA, FGB or FGG genes. Inheritance is most often autosomal dominant or codominant, but can also be autosomal recessive. Whether a person has no symptoms, a bleeding tendency, or an increased risk of thrombosis depends on the effect of their specific genetic change(s). Acquired Dysfibrinogenemia is more common than the congenital form and is associated with liver disease such as cirrhosis, liver tumors, or hepatitis.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/2004\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"familial-dysfibrinogenemia","sourceDocuments":[{"name":"GARD: Familial dysfibrinogenemia","reviewed":null,"source_release":"2026-10-25T03:38:37Z","url":"https://rarediseases.info.nih.gov/diseases/2004"},{"name":"MONDO: familial dysfibrinogenemia","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0014452"}],"sourceNote":"","synonyms":["congenital dysfibrinogenemia","dysfibrinogenemia","dysfibrinogenemia, familial","familial dysfibrinogenemia","hypodysfibrinogenemia"],"takeawayHtml":"","title":"familial dysfibrinogenemia"},"schemaVersion":1}
